跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 15 条关于
“Optejet”
全部
15
临床试验
4
药物
0
机构
0
资讯
11
去年
Eyenovia and Betaliq Plan Reverse Merger to Create Innovative Ophthalmic Technology Company
去年
Eyenovia's Phase 3 CHAPERONE Study Fails to Meet Primary Endpoint for Pediatric Myopia
去年
Eyenovia's Phase 3 CHAPERONE Study Fails to Meet Primary Endpoint in Pediatric Myopia
去年
Eyenovia Reports Q3 2024 Results: Clobetasol Launch and Myopia Program Advance
去年
Eyenovia's Myopia Trial Fails, Stock Plummets
去年
Eyenovia's Stock Plummets After Phase III Myopia Trial Fails to Meet Primary Endpoint
去年
Eyenovia's Phase 3 CHAPERONE Study Fails to Meet Primary Endpoint in Pediatric Myopia
去年
Eyenovia Launches Clobetasol Propionate Ophthalmic Suspension for Post-Ocular Surgery Inflammation and Pain
去年
FDA Accepts Sobi's Avatrombopag (DOPTELET®) Application for Pediatric ITP Treatment
去年
FDA Approves Doptelet for Pediatric Immune Thrombocytopenia with New Sprinkle Formulation
第 1 页,共 2 页
上一页
下一页